The landscape of dementia analysis has advanced drastically with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based exams which can detect Alzheimer's pathology many years ahead of symptoms emerge. Although these technological advancements stand for exceptional progress in knowledge neurod